tiprankstipranks
Trending News
More News >
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market

Bright Minds Biosciences (DRUG) Financial Statements

Compare
269 Followers

Bright Minds Biosciences Financial Overview

Bright Minds Biosciences's market cap is currently $859.37M. The company's EPS TTM is $-0.43916157; its P/E ratio is -71.26; Bright Minds Biosciences is scheduled to report earnings on December 24, 2025, and the estimated EPS forecast is $-0.93. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -76.87KC$ -73.36KC$ -72.45KC$ -6.04KC$ 0.00
Operating IncomeC$ -13.94MC$ -2.81MC$ -7.37MC$ -14.74MC$ -8.76M
EBITDAC$ -12.12MC$ -2.72MC$ -7.28MC$ -14.73MC$ 0.00
Net IncomeC$ -12.23MC$ -2.80MC$ -7.37MC$ -15.19MC$ -8.52M
Balance Sheet
Cash & Short-Term InvestmentsC$ 82.91MC$ 5.72MC$ 6.75MC$ 11.63MC$ 19.76M
Total AssetsC$ 84.42MC$ 6.10MC$ 6.88MC$ 12.09MC$ 20.04M
Total DebtC$ 125.78KC$ 118.96KC$ 73.55KC$ 139.91KC$ 0.00
Net DebtC$ -82.78MC$ -5.60MC$ -6.67MC$ -11.49MC$ -19.76M
Total LiabilitiesC$ 2.38MC$ 568.26KC$ 280.86KC$ 1.54MC$ 638.57K
Stockholders' EquityC$ 82.04MC$ 5.54MC$ 6.60MC$ 10.54MC$ 19.40M
Cash Flow
Free Cash FlowC$ -8.69MC$ -1.85MC$ -7.02MC$ -13.59MC$ -7.32M
Operating Cash FlowC$ -8.69MC$ -1.85MC$ -7.02MC$ -13.59MC$ -7.32M
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 85.57MC$ 810.57KC$ 2.19MC$ 5.20MC$ 26.06M
Currency in CAD

Bright Minds Biosciences Earnings and Revenue History

Bright Minds Biosciences Debt to Assets

Bright Minds Biosciences Cash Flow

Bright Minds Biosciences Forecast EPS vs Actual EPS